Two-Year Data Reinforce Effect of ACTEMRA(R) (tocilizumab) in Inhibiting Progression of Joint Damage and Improving Physical Function in Rheumatoid Arthritis Patients
... progression of both joint erosion and joint
space narrowing, was lower among ACTEMRA (8 mg/kg and 4 ... no progression of either joint erosion or joint
space narrowing, as measured by the Genant-modified ... representing "destruction of the joint." Joint
space narrowing scores are assigned to each of the ...
New Study Demonstrated ACTEMRA(R) (tocilizumab) Inhibited Progression of Joint Damage in Rheumatoid Arthritis Patients
... no progression of
either joint erosion or joint
space narrowing, as measured by the
Genant-modified ... erosion and 13 sites for narrowing of the joint
space both
key measures of ongoing structural damage to ... representing "destruction of the joint." Joint
space narrowing
scores are assigned to each of the ...
Data Demonstrated ACTEMRA(R) (tocilizumab) Significantly Inhibited Progression of Structural Joint Damage in Rheumatoid Arthritis Patients
... "no erosion" and 3.5 representing "destruction of the joint." Joint
space narrowing scores are assigned to each of the specified sites, with 0 ... Increases in the scores indicate the extent of additional erosion, joint
space narrowing or overall structural damage (both scores combined) that have ...
CEL-SCI Corporation Releases Letter to Shareholders
... is great. For years most investors have shunned the cancer immunotherapy
space because of the many failures of various companies involved in the space. ... other immunotherapy approaches have failed, the whole cancer immunotherapy
space has been so tainted that it was almost impossible to be heard. The ...
Scientists Discover Why Teeth Form in a Single Row
... in the womb, the development of teeth and palate are tightly controlled in
space and time by gene expression. Related abnormalities result in the ...
The current study provides the first solid proof that the precise
space where mammals can develop teeth (the "tooth morphogenetic field") is ...
The Pittsburgh Life Sciences Greenhouse Relocates Therapeutics Company to Pittsburgh
... capital and equipment
sources. The Cognition team is occupying office
space in the PLSG Incubator
and laboratory
space on the South Side.
Cognition is an early-stage biopharmaceutical company ...
Award-Winning Medicine Wheel Returns to the Cyclorama at the Boston Center for the Arts on Dec. 1 for 24-hour Vigil Recognizing World AIDS Day
... AIDS Day,
Dec. 1. The annual event was named Best Project in a Public
space by the
Association Int'l des Critiques d'Art's New England Chapter in ... Shufro, president and CEO of Boston Center for the Arts. "Our
flexible
space is ideal for Michael's tremendously versatile, creative
expression each ...
Studies Suggest Key Correlation Between Lung Cancer Subtype and Treatment Outcomes
... to
reduce the incidence and severity of skin rash. The effect of third
space fluid, such as pleural effusion and ascites,
on ALIMTA is unknown. In patients with clinically significant third
space fluid,
consideration should be given to draining the effusion prior to ...
Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment
... through the arteries directly to the problem site in the brain. The coils, or mesh wires, are then inserted into the aneurysm in order to prevent the
space from filling with blood and rupturing.
Approximately two million people in the United States have an unruptured aneurysm. It is estimated ...
Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs
... Mayor Bloomberg. "We set out to create the East River Science Park to provide today's bioscience companies with the state-of-the-art commercial lab
space they need to locate and expand. Eli Lilly and Company's decision to become its anchor tenant is evidence that our work is paying off. It also ...
Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease
... than 38,000 students across three campuses representing 50 states and 124 nations, the UA is on the forefront of discoveries -- from the depths of
space to the medical and genetic mysteries of life, from emerging trends in climate change to the broad complexities of the human condition. For more ...
MADIT-CRT Trial Meets Primary Endpoint
... designed and well executed clinical trial. Boston Scientific is proud to continue the tradition of supporting advances in indications in the CRM
space through trials like MADIT-CRT. More than 80 percent of U.S. patients who receive an ICD or CRT-D were first indicated for this therapy by a clinical ...
VivoMetrics(R) Introduces Next Generation LifeShirt Prototype, a Smart Garment That Delivers Real-time Vital Signs Remotely to Healthcare Providers
... won't use it," says Howard R. Baker, VivoMetrics' president and chief executive officer. "The key to strong adoption and sustainability in the RPM
space will be highly dependent on both patient and provider compliance. It's exciting for us to be able to draw upon over 10 years of experience acquiring ...
Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery
... to the length of some of these URLs, it may be necessary to copy and
paste the hyperlinks into your Internet browser's URL address field. Remove
the
space if one exists.)
Notes to Editors
About Glivec(R) (Glivec)
Glivec is approved in more than 90 countries including the US, EU ...
Paloma Pharmaceuticals Presents at the Association for Research in Vision and Ophthalmology 2009 Meeting
... the retina, many cell types undergo proliferation and consequently have the potential to form retinal scars. When such cell types are present in the
space between the retina and the RPE, subretinal fibrosis is the result and can prevent the recovery of photoreceptor cells even though the retina is ...
Lions Eye Institute for Transplant & Research, Inc. Launches Multi-Million Dollar, State-of-the-Art Research Institute that Will Advance the Study of Blinding Eye Diseases
... facility will offer high-volume, high-quality human ocular tissue for research, study, collaboration, and clinical advancements, as well as extensive
space for on-site residence, sleeping quarters, and meetings/events.
This marks an expansion of the current 35,000 square-foot Tampa Eye Bank ...
Quark Pharmaceuticals Presents at Asia TIDES Conference
... the first to administer a siRNA drug systemically in humans. Our proprietary structures have supplied us with freedom to operate in the siRNA IP
space and Quark is currently developing a pipeline of novel synthetic siRNA compositions starting with QPI-1007."
Dr. Thompson has been at the ...
Wayne County Partners With TechTown to Launch Global Stem Cell 'Innovation and Commercialization Lab'
... resource."
According to Charlton, the lab is particularly valuable to small start-up companies, which rarely have the capital to afford the
space and high-tech equipment that the Stem Cell Commercialization Center will provide. He added that companies will also have access to TechTown's ...
Sangamo BioSciences Provides Update on Company's 2008 Progress and 2009 Objectives
... ZFP Nucleases (ZFN(TM))
for gene modification. Sangamo has established strategic partnerships with
companies outside of the human therapeutic
space including Dow AgroSciences,
Sigma-Aldrich Corporation and several companies applying its ZFP technology to
enhance the production of protein ...
Battelle Scientists Named on Patent for Making Oxygen From Light and Water
... PDEC is an important step forward to produce oxygen
and trap carbon dioxide to maintain breathable air in confined spaces, such
as on submarines, in
space or high altitude flight, or in mine shafts that
become blocked. In the case of an artificial lung, there is ample water in
the blood from which a ...
MicroRNA First Disclosed by Rosetta Genomics may Increase Efficacy of Imatinib (Gleevec(R)(1)) in Glioblastoma
... issued patent relating to microRNAs, as well as patent
applications for a large portion of today's known microRNAs, positions us
to lead the microRNA
space and advance patient care worldwide. Our first
microRNA-based products, diagnosing various cancers, are expected to be
launched later this year."
In ...
Doctor Declares War on Hospital Infections, Patents MRSA-Killing Machine
... C. diff, VRE, E. coli, acinetobactor, and a
host of other infectious diseases. An unexpected benefit of TRU-D is that
the air within the treated
space is disinfected by default, preventing
airborne pathogens from later re-colonizing sterile surfaces.
Dr. Deal licensed the worldwide distribution ...
Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells
... ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo
has established strategic partnerships with companies outside of the human
therapeutic
space including Dow AgroSciences, Sigma-Aldrich Corporation and
several companies applying its ZFP Technology to enhance the production of
protein ...
Small Business Innovation Research Program Awards Grant to Biomoda
... of Homeland Security, Agriculture, Commerce, Defense,
Education, Energy, Transportation, Health and Human Services, National
Aeronautics and
space Administration, Environmental Protection Agency, and
the National Science Foundation.
Biomoda's technology is designed for early lung cancer ...
Kansas Invests Millions in Innovations to Improve Human Health and Launches Three National Bioscience Programs at BIO'08
... to meet significant increases in the demand for clinical studies.
The company is making a capital investment of over $1 million, doubling its
floor
space with a dedicated 50-bed clinical research facility for Phase I
trials, and hiring 38 full- and part-time employees over the next three
years.
...
Transdel Initiates Ketotransdel(TM) Phase 3 Clinical Program for Pain
... due to their relationship as a strategic partner with us, but
because of their cost efficient approach to the clinical program, expertise
in the pain
space and our direct access to their senior executive
management."
"We are enthusiastic about our new strategic relationship with ...
Sangamo BioSciences Announces Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
... ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo
has established strategic partnerships with companies outside of the human
therapeutic
space including Dow AgroSciences, Sigma-Aldrich Corporation and
several companies applying its ZFP Technology to enhance the production of
protein ...
Sangamo BioSciences Provides Update on Diabetic Neuropathy Clinical Programs
... ZFP Nucleases (ZFN(TM)) for gene modification. Sangamo
has established strategic partnerships with companies outside of the human
therapeutic
space including Dow AgroSciences, Sigma-Aldrich Corporation and
several companies applying its ZFP Technology to enhance the production of
protein ...
OxyBand Technologies, Inc. Hires a Leader in Medical Technology as Chief Technology Officer
... medical equipment companies, Varian Medical
Systems, Phillips Medical Systems, Siemens A.G. and Thales.
Dr. Postel has an extensive background in
space propulsion systems and
gas chemistry, beginning his career as a Staff Scientist at Stanford
University's Plasma Propulsion Lab. He later leveraged ...
Magellan Biosciences Companies to Feature Automated Products and New Tests for MRSA at the American Society for Microbiology Meeting, Booth 743
... treatment decisions. Today, there's a
critical shortage of qualified laboratory personnel, and most
hospital-based microbiology labs have neither the
space nor throughput
requirements to justify large-scale automated systems. That's why Dynex
designed the easy-to-use DS2 system, which delivers ...
Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
... (Due to the length of this URL, it may be
necessary to copy and paste this hyperlink into your Internet browser's URL
address field. Remove the
space if one exists.)
Notes to editors
About ELAPRASE(R)
ELAPRASE is a purified form of the lysosomal enzyme
iduronate-2-sulfatase and is produced by ...
BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
... samples will be handled and
managed at BARC's facilities in Johannesburg.
For this operation, BARC South Africa will be increasing its capacity
and
space of its premises in Johannesburg. In addition to its offices
there, BARC also has important lab facilities in Durban, Cape Town, and
Pretoria.
Julie ...
Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
... the lung pleural is difficult to
differentiate from other tumors in the lung pleura, such as primary lung
adenocarcinoma protruding into the pleural
space and metastatic
adenocarcinoma from other tissues. Rosetta Genomics' scientists
investigated the microRNA expression profiles of lung mesothelioma ...
Siemens and LabCorp Enter Agreement to Co-Develop New Clinical Diagnostic Tests
...
gur es_2007.asp (Due to length of URL, Please copy and paste link into
browser. Remove the
space if one exists).
...
Pew Commission Says Industrial Scale Farm Animal Production Poses 'Unacceptable' Risks to Public Health, Environment
... hens) often so severely restricts movement and natural behaviors,
such as the ability to walk or lie on natural materials, having enough
floor
space to move with some freedom, and rooting for pigs, that it
increases the likelihood that the animals suffer severe distress.
Good animal welfare ...
Sangamo BioSciences Announces Presentation of Data on ZFP Therapeutic for Glioblastoma at American Association for Cancer Research (AACR) Meeting
... ZFP Nucleases (ZFN(TM)) for gene
modification. Sangamo has established strategic partnerships with companies
outside of the human therapeutic
space including Dow AgroSciences,
Sigma-Aldrich Corporation and several companies applying its ZFP Technology
to enhance the production of protein ...
RSV Researcher Makes Gains in Finding Treatments
... midst of a fundraising campaign to build
a new state-of-the art hospital. The $327-million facility is scheduled to
open in 2010 and will double the
space for patient care, research and
teaching. For more information, please call (901) 287-6030 or visit
http://www.lebonheur.org .
Available Topic ...
Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of 'Knock-Out' Cell Lines
... ZFP Nucleases (ZFN(TM)) for gene
modification. Sangamo has established strategic partnerships with companies
outside of the human therapeutic
space including Dow AgroSciences,
Sigma-Aldrich Corporation and several companies applying its ZFP Technology
to enhance the production of protein ...
Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
... ZFP Nucleases (ZFN(TM)) for gene
modification. Sangamo has established strategic partnerships with companies
outside of the human therapeutic
space including Dow AgroSciences,
Sigma-Aldrich Corporation and several companies applying its ZFP Technology
to enhance the production of protein ...
Hospital Launches Landmark Emergency Medicine Project
... pressure isolation rooms to prevent spread of infectious agents -- Oversized rooms that can be used for up to three patients -- Clinical lab
space in the Emergency Department to expedite blood tests -- Rooms that can be sterilized with vaporized hydrogen peroxide (Steris, Inc) -- Walls ...